Cancer drug trial halted early: what we know
NCT ID NCT06760702
First seen Apr 28, 2026 · Last updated Jun 12, 2026 · Updated 5 times
Summary
This study tested a new drug called AUR 109 in 29 people with colorectal, ovarian, or kidney cancer who had already tried other treatments. The goal was to see if different doses could shrink tumors and how safe the drug was. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gindodi Devi Hospital
Khursīpār, Chhattisgarh, 490012, India
-
Kiran Multi Super Speciality Hospital and Research Centre
Surat, Gujarat, 395004, India
-
Sujan Surgical Cancer Hospital and Amravati Cancer Foundation
Amravati, Maharashtra, 444605, India
-
Sunshine Global Hospitals
Surat, Gujarat, 395007, India
-
Uro-Science Centre, S.P. Medical College & AG of Hospitals
Bikaner, Rajasthan, 334003, India
Conditions
Explore the condition pages connected to this study.